Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.

Slides:



Advertisements
Similar presentations
Retrovirally Transduced CD34++ Human Cord Blood Cells Generate T Cells Expressing High Levels of the Retroviral Encoded Green Fluorescent Protein Marker.
Advertisements

Figure 1. CD11b+CD33+CD14+HLA-DR−/lo myeloid-derived suppressor cell expansion by human immunodeficiency virus.
by Theresa Tretter, Ram K. C
Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation by Juliette Mouriès, Gabriel Moron, Géraldine Schlecht,
Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells by Yohei Iwata, Takashi Matsushita, Mayuka.
Involvement of suppressors of cytokine signaling in toll-like receptor–mediated block of dendritic cell differentiation by Holger Bartz, Nicole M. Avalos,
Notch signaling induces cytoplasmic CD3ϵ expression in human differentiating NK cells by Magda De Smedt, Tom Taghon, Inge Van de Walle, Greet De Smet,
Melanoma donor (MD) NK cells are functionally impaired/exhausted.
by JoAnn Castelli, Elaine K
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 
Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators by Rikke Bæk Sørensen, Sine Reker Hadrup, Inge Marie Svane, Mads Christian.
by Masih Ostad, Margareta Andersson, Astrid Gruber, and Anne Sundblad
by Rui Zhang, Jeffrey D. Lifson, and Claire Chougnet
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses by Giulia Nizzoli, Jana Krietsch, Anja Weick, Svenja.
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Volume 136, Issue 4, Pages e3 (April 2009)
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer by Ou Cao, Eric Dobrzynski,
by Silke Huber, Reinhard Hoffmann, Femke Muskens, and David Voehringer
Volume 135, Issue 6, Pages (December 2008)
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment by.
by Norman Nausch, Ioanna E
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
Mature dendritic cells pulsed with freeze–thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte.
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans by Güllü Topal Görgün, Gregory Whitehill,
Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells by Ellen J. Wehrens, Gerdien.
by Sheng F. Cai, Xuefang Cao, Anjum Hassan, Todd A
Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance  Oscar Palomares, PhD,
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses by Cagan Gurer, Till.
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection by.
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper by Haifa Hamdi, Véronique.
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression by Giovanna Borsellino, Markus Kleinewietfeld,
CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors  Xupeng.
Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell–Suppressor Mechanisms  Lauren Y. Cao, Jin-Sung Chung,
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms.
IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets by Maria Nikolova, Jean-Daniel Lelievre, Matthieu.
Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases  Zaruhi Hovhannisyan,
TGF-β combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion.
Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15 by Lazar.
Nitric oxide induces human CLA+CD25+Foxp3+ regulatory T cells with skin-homing potential  Cunjing Yu, PhD, Amanda Fitzpatrick, PhD, Duanduan Cong, MMedSci,
by Anil Dangi, Lei Zhang, Xiaomin Zhang, and Xunrong Luo
Volume 18, Issue 5, Pages (May 2003)
Volume 35, Issue 6, Pages (December 2011)
Norito Katoh, Fujiko Soga, Takeshi Nara, Koji Masuda, Saburo Kishimoto 
Volume 140, Issue 1, Pages e3 (January 2011)
Volume 137, Issue 5, Pages (November 2009)
Targeting PKC in Human T Cells Using Sotrastaurin (AEB071) Preserves Regulatory T Cells and Prevents IL-17 Production  Xuehui He, Hans J.P.M. Koenen,
Volume 15, Issue 4, Pages (April 2007)
Volume 27, Issue 2, Pages (August 2007)
Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell- Polarizing Myeloid Dendritic Cells  Lisa C. Zaba, Judilyn Fuentes-Duculan,
Dysregulation of proinflammatory versus anti-inflammatory human TH17 cell functionalities in the autoinflammatory Schnitzler syndrome  Rebecca Noster,
Atul Sathe, Sterling B. Ortega, Dorothy I. Mundy, Robert H
Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible.
A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus  Madhvi Menon, Paul A. Blair,
Volume 135, Issue 1, Pages (July 2008)
A Two-Step Process for Thymic Regulatory T Cell Development
Volume 28, Issue 6, Pages (June 2008)
Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells  Matthieu Allez, Jens Brimnes, Iris Dotan, Lloyd.
Volume 22, Issue 2, Pages (February 2005)
Volume 128, Issue 7, Pages (June 2005)
Volume 17, Issue 2, Pages (February 2009)
Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3–positive regulatory T cells  Amir H. Massoud, MSc,
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Volume 131, Issue 6, Pages (December 2006)
PD-1 blockade enhances T-cell function.
Rapamycin inhibits IL-4—induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo by Holger Hackstein, Timucin Taner,
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 
Volume 10, Issue 5, Pages (February 2015)
A Key Role of Leptin in the Control of Regulatory T Cell Proliferation
Presentation transcript:

Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi K. Banerjee, Madhav V. Dhodapkar, Elyana Matayeva, Ralph M. Steinman, and Kavita M. Dhodapkar Blood Volume 108(8):2655-2661 October 15, 2006 ©2006 by American Society of Hematology

Comparison of different cell populations for the induction of CD4+CD25+ FOXP3+ Treg's. Comparison of different cell populations for the induction of CD4+CD25+ FOXP3+ Treg's. (A) Purified CD3+ T cells were cultured alone or with the indicated populations: myeloid DCs (Myel DCs), plasmacytoid DCs (PDCs), monocytes (Monos) and B cells. After 7 days of culture, the frequency of CD4+ FOXP3+ Treg's was assessed by FACS and compared with the frequency of the CD4+ FOXP3+ Treg's at day 0. Data show a summary of 2 experiments. *P < .05 for comparisons with myeloid DCs. (B) The graph depicts fold changes in numbers of CD4+ FOXP3+ Treg's at day 0 compared with numbers after culture either alone or with myeloid DCs (Myel DCs), plasmacytoid DCs (PDCs), monocytes (Monos), or B cells. *P < .05 for comparisons with myeloid DCs. (C) The amount of FOXP3 protein per CD4+ FOXP3+ cell was examined by determining the geometric mean fluorescence of the FOXP3 expression by FACS at day 7. *P < .05 for comparisons with myeloid DCs. Data shown represent means ± SD. Devi K. Banerjee et al. Blood 2006;108:2655-2661 ©2006 by American Society of Hematology

Expansion of CD4+CD25+ FOXP3+ Treg cells by monocyte-derived cytokine-matured DCs. (A) CD3 purified T cells were cultured alone or with monocyte-derived Cyt-DCs in the absence or presence of graded doses of IL-2 (0-200 U/mL). Expansion of CD4+CD25+ FOXP3+ Treg cells by monocyte-derived cytokine-matured DCs. (A) CD3 purified T cells were cultured alone or with monocyte-derived Cyt-DCs in the absence or presence of graded doses of IL-2 (0-200 U/mL). After 7 days, the numbers of CD4+ FOXP3+ Treg's were monitored by flow cytometry. Data (mean ± SD) show a summary of 5 experiments. P < .05 for comparisons with Cyt-DCs. (B) T cells were cultured either alone or with Cyt-DCs, and CD4+ FOXP3+ T cells were enumerated by FACS on days 0, 1, 2, 4, and 7. Data (mean ± SD) show a summary of 2 experiments. (C) T cells were labeled with CFSE and cultured alone or with Cyt-DCs, and proliferation monitored by flow cytometry on day 5. The figure represents 1 of 4 similar experiments. Devi K. Banerjee et al. Blood 2006;108:2655-2661 ©2006 by American Society of Hematology

Induction of FOXP3+ T cells in CD4+CD25- T cells by DCs Induction of FOXP3+ T cells in CD4+CD25- T cells by DCs. (A) CD25- T cells were isolated by flow sorting and cultured alone (T alone) or with Cyt-DCs. Induction of FOXP3+ T cells in CD4+CD25- T cells by DCs. (A) CD25- T cells were isolated by flow sorting and cultured alone (T alone) or with Cyt-DCs. After 7 days of culture, CD4+CD25+ FOXP3+ T cells were monitored by flow cytometry. One of 4 similar experiments. (B) CD25- T cells were cultured alone or with Cyt-DCs, and expression of FOXP3 protein was monitored by flow cytometry on days 0, 1, 4, and 7 of culture. The graph shows a summary of 2 experiments (mean ± SD). Devi K. Banerjee et al. Blood 2006;108:2655-2661 ©2006 by American Society of Hematology

Generation of FOXP3+ cells by cytokine matured DCs is contact, CD80/CD86, and IL-2 dependent. Generation of FOXP3+ cells by cytokine matured DCs is contact, CD80/CD86, and IL-2 dependent. (A) T cells were cultured with Cyt-DCs in the presence or absence of transwell inserts. Data (mean ± SD) shown in the left panel are CD4+FOXP3+ cells expressed as a percentage of control cultures with no transwells. *P < .05. The representative FACS plots on the right are from 1 of the 3 experiments summarized in the panel on the left. (B) T cells were cultured with Cyt-DCs treated with anti-CD80 and anti-CD86 antibodies (1-5 μg/mL each), anti-IL-2 antibody (1-5 μg/mL), or isotype control. Data (mean ± SD) shown in the panel on the left are CD4+FOXP3+ cells expressed as a percentage of control cultures with isotype mAb-treated DCs.*P < .05. The representative FACS plots on the right are from 1 of the 3 experiments summarized in the panel on the left. The numbers in the FACS plots represent percentage of cells in that quadrant. Devi K. Banerjee et al. Blood 2006;108:2655-2661 ©2006 by American Society of Hematology

Effect of DC maturation stimulus on expansion of Treg's. Effect of DC maturation stimulus on expansion of Treg's. (A) Maturation status of immature DCs (IDC) or DCs matured with inflammatory cytokines (Cyt-DC), FcγRIIB blockade (RIIB), CD40 ligand (CD40L), poly I:C, or LPS was monitored by examining the surface expression of CD83, CD80, CD86, and HLA-DR. The figure represents 1 of 3 similar experiments. (B) T cells were cultured either alone (T alone), or with immature DCs (IDC), or DCs matured with inflammatory cytokines (Cyt-DC), FcγRIIB blockade (RIIB), CD40 ligand matured DCs (CD40L), or the Toll-like receptor ligands poly I:C, or LPS. After 7 days of culture, the presence of FOXP3+ T cells was monitored by flow cytometry. The figure represents 1 of 5 similar experiments. The numbers represent the percentage of FOXP3high cells in the gated area. (C) As in panel B, different types of mature DCs were tested for the ability to induce Treg's in the CD4+ CD25- population. The plots represent 1 of 3 similar experiments. Devi K. Banerjee et al. Blood 2006;108:2655-2661 ©2006 by American Society of Hematology

Suppressive function of DC-induced Treg's. Suppressive function of DC-induced Treg's. (A) T cells were cultured with DCs for 7 days, and the cocultures were labeled with CD25 PE and CD11c FITC. Cell sorting was used to obtain CD25high and CD25- fractions of CD11c- cells. The plot shows the postsort purity of the fractions used as suppressors in the MLR. (B) Suppression of the allogeneic MLR by Treg's induced by mature DCs. Mature DCs (from the same donor as used to generate the CD25+ FOXP3+ T cells) were cultured with CFSE labeled allogeneic responder T cells at a ratio of 1:10. CD25+ suppressors (middle panel) and CD25- cells (bottom panel) obtained via cell sorting were added to the cultures at suppressor-responder ratios of 1:3 to 1:30. Three to 4 days later, flow cytometry was performed to determine the proliferation in the cultures. Top panel shows control MLR without any cells added. (C) FOXP3+ Treg's were generated by culturing T cells with either Cyt-DCs or FcγRIIB blockade-matured DCs (RIIB-DC). Seven days later, DC-expanded T cells were subjected to cell-sorting as in panel A, and CD25+ and CD25- populations were obtained and used as suppressors. The MLR was set up with mature DCs (stimulators) and CFSE-labeled allogeneic T cells as responders as in panel B. The sorted CD25+ and CD25- T cells were added to compare the suppressive ability of the Treg's generated by DCs matured by 2 different maturation stimuli. (D) Bulk CD3+ T cells and sorted CD3+ CD25- T cells were cocultured with Cyt-DCs. After 7 days of coculture, T cells from both conditions were flow sorted to obtain CD25high as well as CD25- T cells as described in panel A. The CD25+ and CD25- cells were used as suppressors in an MLR. The MLR was set up with mature DCs and CFSE-labeled allogeneic T cells as responders as in panel B, and the CD25+ and CD25- populations were added to compare the suppressive ability of the Treg's generated from either bulk T cells or CD25- T cells (de novo Treg's). Devi K. Banerjee et al. Blood 2006;108:2655-2661 ©2006 by American Society of Hematology

Expansion of FOXP3+ Treg's by DCs from patients with myeloma. Expansion of FOXP3+ Treg's by DCs from patients with myeloma. (A) CD14- cells were used as the source of T cells and either cultured alone or with autologous cytokine-matured DCs. Seven days later, FOXP3+ CD4+ T-cell numbers were examined by flow cytometry and compared with those seen in fresh blood at the time of blood draw. Numbers represent percentage of cells in that quadrant. (B) Results show mean (±SD) FOXP3+ CD4+ T-cell expansions from 3 different patients. Left panel shows expansion of CD4+ FOXP3+ T cells at the time of blood draw (day 0), and after 7 days of culturing T cells alone (T alone) and with cytokine matured DCs (T + Cyt-DCs). The right panel shows the geometric mean fluorescence of the FOXP3 expression in CD4+ FOXP3+ T cells before and after culture. (C) CD25+ and CD25- T cells were sorted after 7 days of culture with cytokine-matured DCs as described in Figure 5. An MLR was set up using patient DCs as stimulators and CFSE-labeled allogeneic T cells as responder cells at a 1:10 ratio. Patient CD25+ and CD25- cells were added as suppressors at a ratio of 1:3 to 1:30. Four days later, flow cytometry was performed to determine the proliferation of the CFSE-labeled responder cells. Figure represents 1 of 2 similar experiments. (D) Cytokine-matured DCs expand FOXP3+ CD4+ T cells in vivo. Flow cytometry was performed to examine FOXP3 expression in T cells before and after injection of cytokine-matured DCs in 4 patients. (E) The kinetics of FOXP3 expansion was examined in 3 patients who showed an increase in FOXP3+ CD4+ T cells. T cells were obtained before injection, 1 to 7 days after, and 28 days after injection of cytokine-matured DCs. Devi K. Banerjee et al. Blood 2006;108:2655-2661 ©2006 by American Society of Hematology